Search

Heron Therapeutics Inc

Lezárt

SzektorEgészségügy

0.31

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

0.3

Maximum

0.32

Fő mutatók

By Trading Economics

Bevétel

2.6M

-5.5M

Értékesítés

3M

38M

Egy részvényre jutó nyereség

-0.03

Profit margin

-14.573

Munkavállalók

128

EBITDA

2.1M

-5.5M

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 3.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-36M

60M

Előző nyitás

0.31

Előző zárás

0.31

Hangulat hírek alapján

By Acuity

76%

24%

307 / 340 Rangsor szerint Healthcare

Heron Therapeutics Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. szept. 1. 23:56 UTC

News

Wix.com Ltd faces a securities class action lawsuit over alleged false statements about its AI products, leading shares to trade lower in after-market hours.

2026. szept. 1. 23:56 UTC

News

AbbVie Inc. has filed for a new Skyrizi regimen to treat Crohn's disease. Shares are lower in after-market hours amid broader market pressure from rising oil prices.

2026. szept. 1. 23:51 UTC

News

Telephone and Data Systems withdraws Array Digital Infrastructure acquisition proposal and resumes share repurchase program. Shares rise in after-market trading.

2026. szept. 1. 23:51 UTC

News
Correlated Moves

EOG Resources shares are higher after the company announced participation in the Barclays Energy-Power Conference, with oil prices surpassing $90 per barrel.

2026. szept. 1. 23:46 UTC

News
Correlated Moves

Biontech SE's shares are lower in after-market hours following a decline in Moderna and amid ongoing challenges, including a halted cancer trial.

2026. szept. 1. 23:46 UTC

News

Hormel Foods Corp will participate in the 2026 Barclays Global Consumer Staples Conference. Shares are trading higher during after-market hours following the announcement.

2026. szept. 1. 23:41 UTC

News

StoneX Group Inc shares are lower in after-market hours, reflecting broader market concerns over rising oil prices and ongoing inflation fears amid recent negative trends.

2026. szept. 1. 23:41 UTC

News

Carrier Global shares are higher in after-market trading ahead of the Morgan Stanley conference on September 15, 2026, featuring CEO David Gitlin.

2026. szept. 1. 23:41 UTC

News
Correlated Moves

ONEOK Inc's shares are higher in after-market trading following several rating adjustments, including price target increases from Scotiabank and Morgan Stanley.

2026. szept. 1. 23:41 UTC

News

Dropbox shares fell in after-market hours following a Bloomberg report on a data breach affecting about 5,000 user accounts.

2026. szept. 1. 23:36 UTC

News

G-III Apparel Group has acquired the Marc Jacobs brand from LVMH. Shares are trading higher in after-market hours following the announcement.

2026. szept. 1. 23:36 UTC

News

Quest Diagnostics has signed a multi-year agreement with Renalytix PLC for kidneyintelX.dkd testing, contributing to a modest rise in shares during after-market hours.

2026. szept. 1. 23:31 UTC

News
Social Media

PBF Energy shares advanced in after-market trading following the release of its 2025 Sustainability Data Supplement, amid rising crude oil prices above $90.

2026. szept. 1. 23:31 UTC

News
Correlated Moves
Social Media

Hong Kong's Exchange Fund fell to HK$4.404 trillion in July, with CAD/HKD trading lower amid rising crude oil prices and inflation concerns.

2026. szept. 1. 23:26 UTC

News

Shareholders approve increase of authorized shares to 135 million.

2026. szept. 1. 23:26 UTC

News

Tencent Music Entertainment shares are lower in after-market hours following a proposed public offering of senior unsecured notes for refinancing and share repurchases.

2026. szept. 1. 23:21 UTC

News

Enovix Corp's drone battery portfolio is now TAA-compliant, boosting its U.S. defense supply chain position. Shares are lower in after-market trading amid broader market trends.

2026. szept. 1. 23:21 UTC

News

Lamar Advertising Co declared a quarterly cash dividend of $1.65 per share, up from $1.60, as shares traded lower in after-market hours.

2026. szept. 1. 23:16 UTC

News

BridgeBio Pharma shares are lower in after-market hours following a $500 million mixed securities shelf filing, raising concerns about potential dilution.

2026. szept. 1. 23:16 UTC

News

Emerson Electric is trading higher in after-market hours following multiple analyst rating adjustments and price target changes from various firms.

2026. szept. 1. 23:16 UTC

News

Adecoagro SA completed the R$705 million acquisition of Caarapó Mill, enhancing operations in Mato Grosso do Sul. Shares are trading higher after the announcement.

2026. szept. 1. 23:16 UTC

News

ResMed Inc has initiated a $450 million accelerated share repurchase agreement, contributing to higher shares in after-market trading. Final settlement is set for December 2026.

2026. szept. 1. 23:16 UTC

News

SoFi Technologies Inc shares rose in after-market hours following Scotiabank's initiation of coverage with a Sector Outperform rating and a price target of $25.00.

2026. szept. 1. 23:16 UTC

News
Social Media

Palantir Technologies' subsidiary secured a prime contract with the Army for eight TITAN ground station systems, boosting shares slightly higher in after-hours trading.

2026. szept. 1. 23:16 UTC

News
Correlated Moves
Social Media

CHF/HKD declines amid geopolitical tensions and a decrease in Hong Kong's Exchange Fund assets, which fell to HK$4.404 trillion at July's end.

2026. szept. 1. 23:06 UTC

News
Social Media

Snowflake shares are higher in after-market trading as discussions on social media build ahead of its earnings report, with revenue expectations at $1.48 billion.

2026. szept. 1. 23:06 UTC

News

Union Pacific shares are lower in after-market trading, amid rising oil prices and inflation concerns, despite updates on its merger with Norfolk Southern.

2026. szept. 1. 23:06 UTC

News

Sprouts Farmers Market shares fell in after-hours trading following the announcement of a leadership transition, with Nick Konat set to become CEO in January 2027.

2026. szept. 1. 23:06 UTC

News
Correlated Moves
Social Media

The USD/DKK is trading higher as rising oil prices raise inflation concerns amid geopolitical tensions in the Middle East.

2026. szept. 1. 23:06 UTC

News
Social Media

Alphabet Inc. shares rose in after-hours trading on positive sentiment surrounding its upcoming AI model, Gemini 3.8 Flash, expected to enhance coding capabilities.

Társak összehasonlítása

Árváltozás

Heron Therapeutics Inc Előrejelzés

Értékelési konszenzus

By TipRanks

Semleges

2 ratings

0

Vétel

2

Tartás

0

Eladás

Hangulat

By Acuity

307 / 340 Rangsor szerint Egészségügy

Hangulat hírek alapján

Nagyon erős bearish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Heron Therapeutics Inc

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.
help-icon Live chat